Unlock instant, AI-driven research and patent intelligence for your innovation.

Compounds for the treatment of ischemia-reperfusion injury

A compound and drug technology, applied in the field of compounds for the treatment of ischemia-reperfusion injury, can solve the problems of injury and high mortality in patients with acute myocardial infarction

Active Publication Date: 2020-08-28
武汉惠康达科技有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Although heart bypass surgery, intervention and thrombolysis have made great progress, the mortality rate of patients with acute myocardial infarction is still relatively high. ischemia reperfusion injury

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Compounds for the treatment of ischemia-reperfusion injury
  • Compounds for the treatment of ischemia-reperfusion injury
  • Compounds for the treatment of ischemia-reperfusion injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0146] Example 1 The inhibitory effect of ML355 on liver ischemia-reperfusion injury is dose-dependent

[0147] In order to verify the inhibitory effect of different doses of ML355 on hepatic ischemia-reperfusion injury, C57 mice were randomly divided into 4 groups and injected with 1 mg / kg ML355 (HY-12341, MCE Company), 2 mg / kg ML355, and 3 mg / kg via the tail vein respectively. kg ML355 and solvent (control group, DMSO:Solutol:PEG400:water=5:10:20:65(v:v:v:v)), and then perform I / R surgery according to the method of the aforementioned liver I / R animal model . At different time points after operation, serum and liver tissue were collected for detection of ALT and AST enzyme activity and HE staining.

[0148] The test results of ALT and AST are as follows: Figure 1A , Figure 1B As shown, compared with the solvent control group, after ML355 administration, the contents of ALT and AST in the mouse serum were significantly reduced at 6 hours after operation, and the contents o...

Embodiment 2

[0150] Example 2 ML355 effectively alleviates liver function damage caused by ischemia-reperfusion

[0151] To study the protective effect of ML355 on liver ischemia-reperfusion at different time, C57 mice were randomly divided into 7 groups, 20 in each group. Ten mice in each group were given 3 mg / kg of ML355 dissolved in solvent by tail vein injection, and the other 10 mice were given solvent. After the administration was completed, 7 groups of mice were subjected to I / R surgery (one group was the Sham control group, and the remaining 6 groups were the I / R experimental group), and the Sham control group and postoperative 0h, 1h, 3h, 6h, 12h, 24h I / R experimental group mouse serum, ALT, AST detection, to evaluate the degree of liver function damage; Sham control group and postoperative 0h, 6h I / R experimental group mouse liver tissue, made paraffin sections, TUNEL Staining, Mac1 immunofluorescence staining and Ly6G immunofluorescence staining were used to evaluate the apopto...

Embodiment 3

[0156] Example 3 Inhibition of ML355 on ischemia-reperfusion injury in different tissues

[0157] 1. ML355 inhibits cardiac ischemia-reperfusion injury

[0158] C57 mice were randomly divided into 4 groups (Sham group, I / R 6h group, I / R 12h group, I / R 24h group), 7 mice in the Sham group, and 15 mice in each of the other 3 groups. Seven mice were given 3 mg / kg of ML355 dissolved in solvent by tail vein injection, and the other 8 mice and the Sham group were given solvent. After administration, I / R surgery was performed on the mice in the 4 groups, and the serum of mice in the Sham control group and the I / R experimental group at 6h, 12h, and 24h after operation were collected for CK and LDH detection to evaluate the degree of heart damage.

[0159] Experimental results such as Figure 6A and 6B As shown, the content of CK and LDH in serum increased significantly after I / R. After ML355 was administered through the tail vein, the CK content in serum at each time point after I...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Disclosed is the use of an ALOX12 inhibitor, such as a compound as shown in formula (I) or a pharmaceutically acceptable salt thereof, or a solvate thereof, or a metabolite thereof, in the preparation of a drug for treating ischemia-reperfusion injuries and related diseases, inflammatory diseases, and diseases related to cell death. Ischemia-reperfusion injuries are those of the liver, heart, and kidneys. The inflammatory diseases are hepatitis, myocarditis, endocarditis, and nephritis.

Description

technical field [0001] The present invention belongs to the technical field of medicinal chemistry, especially relates to the compound of formula (I), or its pharmaceutically acceptable salt, or its solvate, or its metabolites in the preparation and treatment of ischemia-reperfusion injury and related diseases, inflammatory diseases, Use in drugs for cell death-related diseases, especially drugs for treating body damage caused by ischemia-reperfusion of organs such as the liver, heart, kidney, and brain. Background technique [0002] Ischemia-Reperfusion Injury (Ischemia-Reperfusion Injury, IRI) is a concept first proposed by Jennings in 1960. It refers to blood reperfusion after tissue and organ ischemia, which not only fails to restore the function of the tissue and organ, but aggravates the dysfunction and structure of the tissue and organ. damage. Ischemia-reperfusion injury can occur in many important organs, including the heart, liver, lung, kidney, and gastrointestin...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/63A61K31/635A61P9/10A61P1/16C07D277/44C07D277/82C07D215/36C07D217/02C07D211/26C07D295/135C07D213/76C07D217/22C07D215/40C07C311/44
CPCA61K31/63A61K31/635C07C311/44C07D211/26C07D213/76C07D215/36C07D215/40C07D217/02C07D217/22C07D277/44C07D277/82C07D295/135
Inventor 李红良张晓晶
Owner 武汉惠康达科技有限公司